Tech Company Financing Transactions
Nascent Pharmaceuticals Funding Round
Nascent Pharmaceuticals secured a $500 thousand funding round on 12/31/2006. Investors included Advantage Capital Partners.
Transaction Overview
Company Name
Announced On
12/31/2006
Transaction Type
Venture Equity
Amount
$500,000
Round
Undisclosed
Investors
Advantage Capital Partners (Douglas Beekman)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
533 Airport Blvd
Burlingame, CA 94010
USA
Burlingame, CA 94010
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Nascent Pharmaceuticals, Inc. is a specialty pharmaceutical company dedicated to acquiring, developing and commercializing innovative new therapeutics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Clive Reading
VP - Bus. Development
Charles du Mee
VP - Regulatory Affairs
Gene Barnett
Browse more venture capital transactions:
Prev: 12/31/2006: Movius venture capital transaction
Next: 12/31/2006: Logical Images venture capital transaction
Share this article
News on VC Transactions
We do our best to document tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs